Maryland Stem Cell Research Fund (MSCRF) Commercialization Award
TEDCO — Maryland Stem Cell Research Fund (MSCRF)
Roughly $300K–$400K per award
Researched for this program: 4 rejection traps · 5 required documentsWhat decides this award ↓
Maryland stem-cell product grant for companies
The MSCRF Commercialization Award funds Maryland for-profit companies — startups and established companies — developing new human stem cell-based products. Administered by the Maryland Stem Cell Research Commission as an independent program within TEDCO, it is a non-dilutive grant intended to advance regenerative-medicine and cell-therapy products toward market. The company is the direct recipient. The award is one of seven MSCRF programs (Launch, Discovery, Validation, Commercialization, Clinical, Post-doctoral Fellowships, and Manufacturing Assistance), of which Commercialization, Launch, and Manufacturing Assistance are company-facing. MSCRF runs regular FY funding cycles; the 2026 summer cycle's deadline was June 23, 2026, and the next FY cycle has not yet been announced.
- Funding type
- Grant
- Level
- State
- Amount range
- $200,000 – $500,000
- Realistic amount
- Per-award amounts have run roughly $270,000–$400,000 based on disclosed cycle totals divided across 3–4 awardees. A typical company should plan around the low-to-mid six figures over a roughly two-year project.
- Deadline
- Submission deadline is January 20, 2027 at 5:00 p.m. EST. Peer review the week of April 4, 2027; awards announced May 2027.
- Status
- active
- States
- Maryland
- Payment model
- milestone
Who qualifies
- Maryland-based for-profit company (start-up or established)
- Developing a new human stem cell-based product
- Work performed in Maryland
- Credible commercialization path for the stem cell-based product
- Compliance with MSCRF/Maryland Stem Cell Research Commission RFA terms
Hard requirements
- Must be an incorporated business
What it covers
Eligible expenses
- Development of human stem cell-based products
- Preclinical/translational and process development toward commercialization
- Personnel working on the funded project in Maryland
- Project-specific materials and supplies
Ineligible expenses
- Work performed outside Maryland
- Costs unrelated to the funded stem cell product
- Activities outside the approved RFA scope
How to apply
-
1
Confirm Commercialization-track eligibility
Verify your company is Maryland-based, for-profit, and developing a human stem cell-based product. Review the active Commercialization RFA on mscrf.org for the current cycle's terms and amount.
~6 hrs
-
2
Prepare the application
Prepare the technical/commercialization plan, budget, team, and required RFA documents per the Commission's guidelines.
~30 hrs
-
3
Submit by the cycle deadline
Submit via the MSCRF online portal by the cycle deadline (e.g., June 23, 2026 for the summer cycle), 5:00 p.m. EST.
~4 hrs
-
4
Commission review and award
The Maryland Stem Cell Research Commission reviews applications and announces awards; awardees execute grant agreements with TEDCO/MSCRF.
~6 hrs
MSCRF is one of the few non-dilutive grant pools specifically for stem cell / regenerative-medicine companies — and Maryland is small enough that the Commission knows the ecosystem, so a Maryland operating footprint and a clear product (not just science) is decisive. The Commercialization track is the company-facing one; Validation is restricted to academic faculty, so apply to the right track.
Deadline & timing
The FY27 Commercialization RFA is live. Applications are due January 20, 2027 by 5:00 p.m. EST (late submissions not considered); peer review and applicant presentation the week of April 4, 2027; awards announced May 2027. Awards are capped at $250,000 (Level 1) or $400,000 (Level 2), rising to $350,000 / $500,000 with a Maryland research-institution collaboration. Funder runs mid-January and mid-July cycles.
Deadline January 20, 2027
Save it to your calendar, with reminders a week and a day before.
Funders sometimes move dates, so check the official page before you apply.
Applications are open — don’t lose the window
GrantCompass tracks Maryland Stem Cell Research Fund (MSCRF) Commercialization Award’s application windows in the live catalog. Leave an email and we’ll warn you before this window closes — and tell you when the next round opens.
Free. One email when the window moves, deadline warnings on your watchlist, and the monthly closing-soon digest. Unsubscribe anytime.
Programs that stack well
Related programs
Also open right now
Alternatives computed from the live GrantCompass catalog on November 21, 2026 — all 177 open grant programs · filter the database.
Explore more funding
Last updated November 19, 2026. GrantCompass is an independent funding-discovery tool and is not affiliated with any government agency. Always confirm details on the official program page.